Lexicon Pharmaceuticals (LX31) Stock Forecast & Price Target
LX31 Analyst Ratings
LX31 Stock 12 Month Forecast
Average Price Target
EUR 5.15▲(411.78% Upside)Detailed List of Analyst Forecasts
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Joseph Pantginis | H.C. Wainwright | EUR 5.35 | buy | 431.72%Upside | Reiterated | 10/27/26 | ||
| Yasmeen Rahimi | Piper Sandler | EUR 5.35 | buy | 431.72%Upside | Reiterated | 10/26/26 | ||
| Yigal Nochomovitz | Citi | EUR 2.77 | buy | 174.72%Upside | Reiterated | 10/25/26 | ||
| Steven Seedhouse | Cantor Fitzgerald | EUR 7.14 | buy | 608.96%Upside | Reiterated | 10/18/26 | ||
 Unknown AnalystNot Ranked | Leerink Partners | EUR 0.89 | hold | -11.38%Downside | Reiterated | 03/06/26 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Joseph Pantginis | 10/27/26 | EUR 5.35 | buy | 431.72%Upside | Reiterated | H.C. Wainwright | ||
| Yasmeen Rahimi | 10/26/26 | EUR 5.35 | buy | 431.72%Upside | Reiterated | Piper Sandler | ||
| Yigal Nochomovitz | 10/25/26 | EUR 2.77 | buy | 174.72%Upside | Reiterated | Citi | ||
| Steven Seedhouse | 10/18/26 | EUR 7.14 | buy | 608.96%Upside | Reiterated | Cantor Fitzgerald | ||
| Unknown AnalystNot Ranked | 03/06/26 | EUR 0.89 | hold | -11.38%Downside | Reiterated | Leerink Partners |
Best Analysts Covering Lexicon Pharmaceuticals
Copying Joseph Pantginis's trades and holding each position for 3 Months would result in 60.00% of your transactions generating a profit, with an average return of +22.87% per trade.
Copying Joseph Pantginis's trades and holding each position for 1 Year would result in 60.00% of your transactions generating a profit, with an average return of +74.22% per trade.
Copying Joseph Pantginis's trades and holding each position for 2 Years would result in 53.33% of your transactions generating a profit, with an average return of +38.97% per trade.
LX31 Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 3 | 5 | 7 | 9 | 6 |
| Buy | 1 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 4 | 5 | 7 | 9 | 6 |
In the current month, LX31 has received 6 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. LX31 average Analyst price target in the past 3 months is 5.15.
LX31 Financial Forecast
LX31 Earnings Forecast
Next quarter’s earnings estimate for LX31 is -EUR 0.05 with a range of -EUR 0.06 to -EUR 0.04. The previous quarter’s EPS was -EUR 0.06. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
LX31 Sales Forecast
Next quarter’s sales forecast for LX31 is EUR 3.70M with a range of EUR 0 to EUR 9.73M. The previous quarter’s sales results were EUR 617.54K. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.